-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMG-355 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMG-355 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMG-355 in Non-Small Cell Lung Cancer Drug Details: AMG-355...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMG-355 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AMG-355 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AMG-355 in Metastatic Colorectal Cancer Drug Details: AMG-355 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Solid Tumor Drug Details: SOF-10 (RG6440) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Gastric Cancer Drug Details: SOF-10 (RG6440) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Non-Small Cell Lung Cancer Drug Details: SOF-10...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Pancreatic Ductal Adenocarcinoma Drug Details: SOF-10 (RG6440) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RG-6115 in Gallbladder Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RG-6115 in Gallbladder Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. RG-6115 in Gallbladder Cancer Drug Details: RG-6115 (RO-7119929) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LCB-84 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LCB-84 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LCB-84 in Solid Tumor Drug Details: LCB-84 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MCLA-129 in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MCLA-129 in Laryngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MCLA-129 in Laryngeal Cancer Drug Details: MCLA-129 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MCLA-129 in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MCLA-129 in Oropharyngeal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MCLA-129 in Oropharyngeal Cancer Drug Details: MCLA-129 is under development for...